Two Sigma Securities’s Amedisys AMED Stock Holding History

Two Sigma Securities’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,900	Closed	-$409K	–	2611
2022 Q4	$409K	Buy	+4,900	New	+$442K	0.01%	1262
2022 Q3	–	Sell	-10,400	Closed	-$1.09M	–	2563
2022 Q2	$1.09M	Buy	+10,400	New	+$1.33M	0.04%	495
2020 Q2	–	Sell	-4,600	Closed	-$844K	–	1352
2020 Q1	$844K	Sell	4,600 -3,500	-43%	-$623K	0.02%	435
2019 Q4	$1.35M	Sell	8,100 -13,600	-63%	-$2.02M	0.01%	898
2019 Q3	$2.84M	Buy	21,700 +3,500	+19%	+$456K	0.03%	473
2019 Q2	$2.21M	Buy	18,200 +10,900	+149%	+$1.29M	0.02%	437
2019 Q1	$900K	Buy	+7,300	New	+$916K	0.01%	593
2018 Q4	–	Sell	-3,600	Closed	-$450K	–	2113
2018 Q3	$450K	Sell	3,600 -4,700	-57%	-$519K	﹤0.01%	1491
2018 Q2	$709K	Buy	+8,300	New	+$609K	﹤0.01%	1560

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Securities's AMED Position: Q2 2025 in Review

Two Sigma Securities sold out of Amedisys (AMED) in Q2 2025, closing a stake of 2,440 shares — an estimated $226K sold.

Two Sigma Securities first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $504K in Q3 2022. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

Two Sigma Securities reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 2,440 Amedisys shares in Q2 2025, an estimated $226K.
Two Sigma Securities first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
Two Sigma Securities's Amedisys position peaked at $504K in Q3 2022.
319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.